CLINICAL_TRIALS
trial_result
· 2017-08-28
Clinical Trial Update: Dasotraline Adult ADHD Study [Phase 3]
Summary
A Phase 3 trial of dasotraline for adults with attention-deficit/hyperactivity disorder has completed. The sponsor is Sumitomo Pharma America, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Adult Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED